Charmacy Pharmaceutical Co., Ltd. (2289.HK)
2289.HK Stock Price Chart
Explore Charmacy Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 2289.HK price movements and trends.
2289.HK Company Profile
Discover essential business fundamentals and corporate details for Charmacy Pharmaceutical Co., Ltd. (2289.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
14 Dec 2015
Employees
847.00
Website
https://www.chmyy.comCEO
Chuanglong Yao
Description
Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online and make inquiries and payments. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is headquartered in Shantou, the People's Republic of China.
2289.HK Financial Timeline
Browse a chronological timeline of Charmacy Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 26 May 2025
A dividend of $0.49 per share was announced, adjusted to $0.49. The dividend was paid on 11 Jul 2025.
Earnings released on 28 Mar 2025
EPS came in at $0.26 , while revenue for the quarter reached $2.22B .
Earnings released on 29 Aug 2024
EPS came in at $0.27 , while revenue for the quarter reached $2.52B .
Dividend declared on 22 May 2024
A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 10 Jul 2024.
Earnings released on 29 Mar 2024
EPS came in at $0.26 , while revenue for the quarter reached $2.36B , missing expectations by -50.98%.
Earnings released on 30 Jun 2023
EPS came in at $0.26 , while revenue for the quarter reached $2.45B .
Dividend declared on 29 Jun 2023
A dividend of $0.50 per share was announced, adjusted to $0.50. The dividend was paid on 31 Jul 2023.
Earnings released on 1 Apr 2023
EPS came in at $0.74 , while revenue for the quarter reached $2.61B , missing expectations by -45.93%.
Earnings released on 31 Aug 2022
EPS came in at $0.22 , while revenue for the quarter reached $2.21B , missing expectations by -54.17%.
Earnings released on 31 Dec 2021
EPS came in at -$0.03 , while revenue for the quarter reached $2.20B .
Earnings released on 30 Jun 2021
EPS came in at $0.29 , while revenue for the quarter reached $2.39B .
Dividend declared on 2 Jun 2021
A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 15 Jul 2021.
Earnings released on 31 Dec 2020
EPS came in at $0.11 , while revenue for the quarter reached $2.53B .
2289.HK Stock Performance
Access detailed 2289.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.